Skip to main content
. 2012 Oct 24;7(10):e47511. doi: 10.1371/journal.pone.0047511

Figure 3. Cost-effectiveness acceptability curve for Rotarix (red) and RotaTeq (black) following vaccine introduction in Kenya modelled over a five year period.

Figure 3

The Societal Perspective (SP) is the solid line, the Health Care Perspective is marked by the dashed line.